279 related articles for article (PubMed ID: 33919790)
21. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy.
Blask DE; Sauer LA; Dauchy RT
Curr Top Med Chem; 2002 Feb; 2(2):113-32. PubMed ID: 11899096
[TBL] [Abstract][Full Text] [Related]
22. The validity of melatonin as an oncostatic agent.
Panzer A; Viljoen M
J Pineal Res; 1997 May; 22(4):184-202. PubMed ID: 9247204
[TBL] [Abstract][Full Text] [Related]
23. Melatonin modulates tumor metabolism and mitigates metastasis.
Reiter RJ; Sharma R; Tan DX; Huang G; de Almeida Chuffa LG; Anderson G
Expert Rev Endocrinol Metab; 2023; 18(4):321-336. PubMed ID: 37466337
[TBL] [Abstract][Full Text] [Related]
24. Melatonin: a modulator in metabolic rewiring in T-cell malignancies.
Rai S; Roy G; Hajam YA
Front Oncol; 2023; 13():1248339. PubMed ID: 38260850
[TBL] [Abstract][Full Text] [Related]
25. Melatonin is a potential oncostatic agent to inhibit HepG2 cell proliferation through multiple pathways.
Ammar OA; El-Missiry MA; Othman AI; Amer ME
Heliyon; 2022 Jan; 8(1):e08837. PubMed ID: 35141433
[TBL] [Abstract][Full Text] [Related]
26. ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation.
Liburdy RP; Sloma TR; Sokolic R; Yaswen P
J Pineal Res; 1993 Mar; 14(2):89-97. PubMed ID: 8320637
[TBL] [Abstract][Full Text] [Related]
27. Fitter Mitochondria Are Associated With Radioresistance in Human Head and Neck SQD9 Cancer Cells.
Grasso D; Medeiros HCD; Zampieri LX; Bol V; Danhier P; van Gisbergen MW; Bouzin C; Brusa D; Grégoire V; Smeets H; Stassen APM; Dubois LJ; Lambin P; Dutreix M; Sonveaux P
Front Pharmacol; 2020; 11():263. PubMed ID: 32231567
[TBL] [Abstract][Full Text] [Related]
28. Anti-cancer activity of a new dihydropyridine derivative, VdiE-2N, in head and neck squamous cell carcinoma.
Goto RN; Sobral LM; Sousa LO; Garcia CB; Lopes NP; Marín-Prida J; Ochoa-Rodríguez E; Verdecia-Reyes Y; Pardo-Andreu GL; Curti C; Leopoldino AM
Eur J Pharmacol; 2018 Jan; 819():198-206. PubMed ID: 29221949
[TBL] [Abstract][Full Text] [Related]
29. Cytotoxic response of tumor-infiltrating lymphocytes of head and neck cancer slice cultures under mitochondrial dysfunction.
Greier MDC; Runge A; Dudas J; Hartl R; Santer M; Dejaco D; Steinbichler TB; Federspiel J; Seifarth C; Konschake M; Sprung S; Sopper S; Randhawa A; Mayr M; Hofauer BG; Riechelmann H
Front Oncol; 2024; 14():1364577. PubMed ID: 38515569
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic actions of melatonin in cancer: possible mechanisms.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Cardinali DP
Integr Cancer Ther; 2008 Sep; 7(3):189-203. PubMed ID: 18815150
[TBL] [Abstract][Full Text] [Related]
31. Effect and mechanism of melatonin's action on the proliferation of human umbilical vein endothelial cells.
Cui P; Luo Z; Zhang H; Su Y; Li A; Li H; Zhang J; Yang Z; Xiu R
J Pineal Res; 2006 Nov; 41(4):358-62. PubMed ID: 17014693
[TBL] [Abstract][Full Text] [Related]
32. Melatonin Exerts Anticancer Effects in Human Tongue Squamous Cell Carcinoma Cells by Promoting Autophagy.
Sung ES; Kim JY; Ahn YT; Lee IW; Choi SW; Jang HB; Lee JC; An WG
Anticancer Res; 2020 Nov; 40(11):6295-6303. PubMed ID: 33109567
[TBL] [Abstract][Full Text] [Related]
33. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways.
Zhang Y; Wang Y; Xu J; Tian F; Hu S; Chen Y; Fu Z
J Pineal Res; 2019 Mar; 66(2):e12542. PubMed ID: 30516280
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells.
Veyrat M; Durand S; Classe M; Glavan TM; Oker N; Kapetanakis NI; Jiang X; Gelin A; Herman P; Casiraghi O; Zagzag D; Enot D; Busson P; Vérillaud B
Oncotarget; 2016 Dec; 7(50):82580-82593. PubMed ID: 27791989
[TBL] [Abstract][Full Text] [Related]
35. Regulation of Glycolysis in Head and Neck Cancer.
Raj S; Kumar A; Kumar D
Adv Exp Med Biol; 2021; 1280():219-230. PubMed ID: 33791985
[TBL] [Abstract][Full Text] [Related]
36. Melatonin prevents age-related mitochondrial dysfunction in rat brain via cardiolipin protection.
Petrosillo G; Fattoretti P; Matera M; Ruggiero FM; Bertoni-Freddari C; Paradies G
Rejuvenation Res; 2008 Oct; 11(5):935-43. PubMed ID: 18928424
[TBL] [Abstract][Full Text] [Related]
37. Regulatory Role of Hexokinase 2 in Modulating Head and Neck Tumorigenesis.
Li WC; Huang CH; Hsieh YT; Chen TY; Cheng LH; Chen CY; Liu CJ; Chen HM; Huang CL; Lo JF; Chang KW
Front Oncol; 2020; 10():176. PubMed ID: 32195170
[TBL] [Abstract][Full Text] [Related]
38. Mitochondria-targeted drugs stimulate mitophagy and abrogate colon cancer cell proliferation.
Boyle KA; Van Wickle J; Hill RB; Marchese A; Kalyanaraman B; Dwinell MB
J Biol Chem; 2018 Sep; 293(38):14891-14904. PubMed ID: 30087121
[TBL] [Abstract][Full Text] [Related]
39. Reduction of Mitophagy-Related Oxidative Stress and Preservation of Mitochondria Function Using Melatonin Therapy in an HT22 Hippocampal Neuronal Cell Model of Glutamate-Induced Excitotoxicity.
Wang DD; Jin MF; Zhao DJ; Ni H
Front Endocrinol (Lausanne); 2019; 10():550. PubMed ID: 31440210
[TBL] [Abstract][Full Text] [Related]
40. Melatonin for prevention of erythema and oxidative stress in response to ultraviolet radiation.
Scheuer C
Dan Med J; 2017 Jun; 64(6):. PubMed ID: 28566124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
